Bulk Pharmaceutical API Sources for TERFONYL

Bulk Pharmaceutical API Sources for TERFONYL

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		S8626_SIGMA
Vitas-M Laboratory		STK317797
TCI (Tokyo Chemical Industry)		S0579
Molport		MolPort-000-629-738
AKos Consulting & Solutions		AKOS000119073

Bulk Active Pharmaceutical Ingredient (API) Sources for: TERFONYL

Last updated: July 30, 2025

---

Introduction

Terfonyl (generic name: terbinafine) is a widely utilized antifungal agent primarily prescribed for the treatment of dermatophyte infections such as athlete's foot, ringworm, and onychomycosis. As a critical pharmaceutical component, the sourcing of high-quality bulk Active Pharmaceutical Ingredients (APIs) is fundamental to manufacturing efficacious and compliant finished products. This report provides a comprehensive analysis of the current global API suppliers for terbinafine, including their manufacturing capabilities, regulatory standing, and market positioning.

---

Overview of Terbinafine API Production

Terbinafine hydrochloride, the active form used in pharmaceuticals, originates from complex chemical synthesis processes that require strict quality controls to ensure potency, purity, and consistency. The primary manufacturing steps involve multi-stage chemical reactions and rigorous purification procedures, often occurring in cGMP-compliant facilities.

While several companies globally produce terbinafine API, their market share, quality standards, and geographic footprints vary significantly. The selection of a supplier hinges on factors such as regulatory approvals (e.g., FDA, EMA, PMDA), certifications, capacity, lead times, and price competitiveness.

---

Major Global API Producers for Terbinafine

1. Zhejiang Hisun Pharmaceutical Co., Ltd. (China)

Overview:
Zhejiang Hisun Pharmaceutical boasts extensive experience in antifungal APIs, including terbinafine hydrochloride. With robust manufacturing facilities in China, the company adheres to international quality standards and has achieved GMP certification recognized globally.

Strengths:

• Large-scale production capacity.
• Approved by regulatory agencies including the FDA and EMA.
• Integrated R&D and manufacturing processes.

Market Presence:
Hisun exports to North America, Europe, and Asia, serving both branded and generic pharmaceutical companies.

2. Hubei Huida Pharmaceutical Co., Ltd. (China)

Overview:
Specializing in antifungal and dermatological APIs, Hubei Huida offers terbinafine API with high purity levels. The company emphasizes rigorous quality assurance processes aligned with international standards.

Strengths:

• Cost-competitive pricing.
• ISO and GMP certifications.
• Focused R&D for process optimization.

Market Presence:
Serving Asian markets extensively, with growing footprints in Europe and North America.

3. Mylan N.V. / Viatris (Global Presence)

Overview:
A major multinational pharmaceutical manufacturer, Mylan (now part of Viatris) produces terbinafine API in facilities compliant with cGMP standards, primarily sourcing from approved manufacturing partners.

Strengths:

• Extensive regulatory experience.
• Supply chain robustness.
• Proven track record in delivering quality APIs for large-scale production.

Note:
While Mylan/Viatris may outsource production, their rigorous supplier qualification processes ensure consistent API standards.

4. Granules India Limited (India)

Overview:
Granules India is a prominent pharmaceutical manufacturer offering a range of APIs, including terbinafine hydrochloride. The company's manufacturing facilities are GMP-certified, ensuring compliance with global quality norms.

Strengths:

• Cost-effective manufacturing.
• Strong distribution networks.
• Focus on quality assurance.

Global Reach:
Exports to North America, Europe, and Middle East.

5. Zhejiang Hisoar Pharmaceutical Co., Ltd. (China)

Overview:
A newer player in the API market, Hisoar Pharmaceutical emphasizes quality and innovation in antifungal APIs production, with growing international recognition.

Strengths:

• Focused R&D capabilities.
• Capacity expansion plans.
• Certifications aligned with global standards.

---

Regulatory and Quality Considerations

For pharmaceutical manufacturers, API sourcing entails stringent compliance with local and international regulations. The suppliers listed above possess key certifications such as:

• GMP (Good Manufacturing Practice): Ensures consistent quality.
• ISO Certifications: Guarantee adherence to quality management systems.
• EMA, FDA Approval: Critical for suppliers serving regulated markets.

Additionally, suppliers must provide comprehensive analytical method validation, stability data, and impurity profiles to ensure API suitability for pharmaceutical production.

---

Market Dynamics and Supply Chain Factors

The terbinafine API market remains characterized by competitive pricing and capacity expansion, driven by increasing global dermatological treatment needs. The recent surge in antifungal drug consumption, especially during the COVID-19 pandemic, has accentuated supply chain vulnerabilities, prompting manufacturers to diversify sourcing strategies.

Manufacturers considering API procurement must evaluate:

• Supply reliability and lead times.
• Price stability and on-time delivery.
• Traceability and documentation quality.
• Regulatory track record and audit history.

In this context, China and India dominate as primary API manufacturing hubs, supported by their extensive chemical synthesis expertise.

---

Emerging Trends and Future Outlook

Increasing demand for high-purity APIs and stricter global regulatory standards are prompting suppliers to invest in advanced manufacturing technologies, including continuous synthesis and enhanced purification methods. Additionally, the quest for green chemistry practices aims to reduce environmental impact and improve process efficiencies.

The integration of digital quality systems and supply chain transparency is expected to improve API sourcing reliability, impacting procurement strategies positively.

---

Key Takeaways

• Market Leaders: Zhejiang Hisun and Granules India are prominent API suppliers, offering high-quality terbinafine suitable for regulated markets.
• Regulatory Compliance: Verified GMP certification is non-negotiable; suppliers should possess approvals aligned with target markets.
• Supply Chain Resilience: Diversifying API sources—balancing Chinese and Indian manufacturers—reduces dependency and mitigates risks.
• Cost and Capacity: Cost competitiveness remains essential, but must be balanced with quality and compliance standards.
• Future Trends: Expect increased investment in sustainable manufacturing processes and digital supply chain enhancement.

---

FAQs

1. What are the key factors in selecting an API supplier for terbinafine?
Regulatory compliance (GMP certification and approvals), manufacturing capacity, product purity, pricing, supply reliability, and supplier reputation.

2. Are Chinese API manufacturers trustworthy for pharmaceutical-grade terbinafine?
Yes, many Chinese manufacturers have achieved international GMP certifications and regulatory approvals, making them reliable sources when vetted properly.

3. How does quality assurance impact API sourcing?
High-quality APIs reduce regulatory risks, prevent manufacturing delays, and ensure product efficacy, making quality assurance critical in procurement decisions.

4. What trends are shaping the terbinafine API market?
Growing demand for antifungal agents, technological advances in synthesis, sustainability initiatives, and supply chain digitization.

5. Is there a rising trend of local API production in regulated markets?
Yes, countries aim to bolster local manufacturing to reduce dependency on imports, especially amidst global supply chain disruptions.

---

References

[1] Market research reports on pharmaceutical APIs, 2022.
[2] WHO GMP guidelines and certifications, 2021.
[3] Company disclosures and certifications from Zhejiang Hisun Pharmaceutical, Granules India, and others.
[4] Industry analysis on global API supply chain trends, 2023.
[5] Regulatory agency approvals and product registrations.

---

This comprehensive review aims to assist pharmaceutical companies, sourcing professionals, and stakeholders in making informed decisions regarding terbinafine API procurement.